体外診断（IVD）検査におけるバイオインフォマティクスの世界市場レポート 2025年

体外診断（IVD）検査におけるバイオインフォマティクス市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は6.8%で、1,298億9,000万米ドルに成長します。予測期間の成長は、疾病の有病率の上昇、ヘルスケアにおけるITの統合、政府の取り組みと資金提供、個別化医療へのシフト、医療提供者の診断におけるバイオインフォマティクスの利点に関する認識向上、ゲノム配列決定のコスト低下に起因すると考えられます。予測期間における主な動向としては、人工知能（AI）と機械学習、次世代シーケンシング、ポイントオブケア（POC）検査、クラウドコンピューティングとビッグデータ、免疫化学的手法の革新などが挙げられます。

IVD（体外診断）検査市場におけるバイオインフォマティクスの成長は、がんの有病率の上昇が牽引すると予想されます。がんとは、細胞の異常増殖を特徴とする疾患群を指し、周辺組織を侵し、身体の他の部位に転移する可能性があります。ライフスタイル、環境の影響、被曝リスクなど様々な要因が、がんの有病率上昇に寄与しています。体外診断用医薬品検査におけるバイオインフォマティクスは、早期発見を改善し、治療決定を導き、患者の転帰を向上させる正確で個別化された遺伝学的洞察を提供することにより、がん診断に変革をもたらしつつあります。例えば、2022年、米国の政府機関であるNational Association of Chronic Disease Directors（NACDD）は、米国成人の約40%が複数の慢性疾患（MCC）を抱えて生活していると報告しました。また、慢性疾患を1つでも抱えていると、特に加齢に伴い、さらなる疾患を発症する可能性が高まるというデータもあります。その結果、がんの有病率の増加がIVD検査市場におけるバイオインフォマティクスの需要に拍車をかけています。

この市場の主要企業は、技術革新、特に次世代シーケンス（NGS）技術に注力しています。NGSは、ゲノム全体または特定のDNA・RNA領域の迅速な塩基配列決定を可能にし、包括的な遺伝子解析を容易にします。例えば、2022年5月、イルミナ・インクはCEマークを取得したTruSight Oncology Comprehensive（EU）検査に汎がんコンパニオン診断（CDx）適応を導入しました。この検査は、神経栄養型チロシン受容体キナーゼ（NTRK）遺伝子融合（NTRK1、NTRK2、またはNTRK3）を保有する固形がん患者で、バイエル薬品のVitrakvi（ラロトレクチニブ）による標的治療が有効な可能性のある患者を同定します。TSO Comprehensive（EU）検査は、次世代シーケンサーを用いた包括的ゲノム・プロファイリング（CGP）を採用しており、1つの生検検体から複数の腫瘍遺伝子とバイオマーカーを解析することで、各患者固有のがん分子プロファイルを決定します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界体外診断（IVD）検査におけるバイオインフォマティクス PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の体外診断（IVD）検査におけるバイオインフォマティクス市場：成長率分析
• 世界の体外診断（IVD）検査におけるバイオインフォマティクス市場の実績：規模と成長, 2019-2024
• 世界の体外診断（IVD）検査におけるバイオインフォマティクス市場の予測：規模と成長, 2024-2029, 2034F
• 世界体外診断（IVD）検査におけるバイオインフォマティクス総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の体外診断（IVD）検査におけるバイオインフォマティクス市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ハードウェア
• ソフトウェア
• 世界の体外診断（IVD）検査におけるバイオインフォマティクス市場テストの種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 血液検査
• 組織ベースの検査
• 世界の体外診断（IVD）検査におけるバイオインフォマティクス市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 心血管疾患
• 慢性疾患
• 糖尿病
• がん
• その他の用途
• 世界の体外診断（IVD）検査におけるバイオインフォマティクス市場、ハードウェアの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• アナライザー
• 実験装置
• データストレージデバイス
• センサーと検出器
• ワークステーションとデータ処理ハードウェア
• 世界の体外診断（IVD）検査におけるバイオインフォマティクス市場ソフトウェアの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• バイオインフォマティクスプラットフォーム
• データ管理および統合ソフトウェア
• 分析および解釈ソフトウェア
• クラウドベースのソフトウェアソリューション
• 診断用AIベースソフトウェア

第7章 地域別・国別分析

• 世界の体外診断（IVD）検査におけるバイオインフォマティクス市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の体外診断（IVD）検査におけるバイオインフォマティクス市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 体外診断（IVD）検査におけるバイオインフォマティクス市場：競合情勢
• 体外診断（IVD）検査におけるバイオインフォマティクス市場：企業プロファイル
  • Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
  • International Business Machines Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Parker Hannifin Corp. Overview, Products and Services, Strategy and Financial Analysis
  • Illumina Inc Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• PerkinElmer Inc.
• QIAGEN N.V.
• Kollmorgen Corp
• Bioreference Laboratories Inc.
• AssureRx Health Inc.
• Biodesix Inc.
• Crescendo Bioscience Inc.
• Affymetrix
• Complete Genomics Inc.
• Aperico Technologies Inc.
• One Lambda Inc.
• Datech Oncology
• Life Technologies
• Signal genetics
• CardioDx Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 体外診断（IVD）検査におけるバイオインフォマティクス市場2029：新たな機会を提供する国
• 体外診断（IVD）検査におけるバイオインフォマティクス市場2029：新たな機会を提供するセグメント
• 体外診断（IVD）検査におけるバイオインフォマティクス市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Bioinformatics in in vitro diagnostics (IVD) involves applying computational methods, data analysis, and software tools to interpret biological data from diagnostic tests conducted outside the living organism. This includes using algorithms and statistical models to process large volumes of molecular and clinical data.

In the realm of bioinformatics in IVD testing, hardware encompasses the physical components and devices used in laboratory and computational settings. These tests, which include blood-based and tissue-based assays, find applications in detecting conditions such as cardiovascular diseases, chronic illnesses, diabetes, cancer, among others.

The bioinformatics in IVD testing market research report is one of a series of new reports from The Business Research Company that provides bioinformatics in IVD testing market statistics, including bioinformatics in IVD testing industry global market size, regional shares, competitors with bioinformatics in IVD testing market share, detailed bioinformatics in IVD testing market segments, market trends, and opportunities, and any further data you may need to thrive in the bioinformatics in IVD testing industry. This bioinformatics in IVD testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The bioinformatics in in-vitro diagnostics (IVD) testing market size has grown strongly in recent years. It will grow from $93.02 billion in 2024 to $99.69 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to improved healthcare infrastructure, expansion of biobanks, rising geriatric population, government initiatives and funding, and growth of personalized medicine.

The bioinformatics in in-vitro diagnostics (IVD) testing market size is expected to see strong growth in the next few years. It will grow to $129.89 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to rising prevalence of diseases, integration of IT in healthcare, government initiatives and funding, the shift towards personalized medicine, enhanced awareness about the benefits of bioinformatics in diagnostics among healthcare providers, and the decreasing cost of genomic sequencing. Major trends in the forecast period include artificial intelligence (AI) and machine learning, next-generation sequencing, point-of-care (POC) testing, cloud computing and big data, and innovations in immunochemical techniques.

The rising prevalence of cancer is expected to drive growth in the bioinformatics in IVD (in vitro diagnostics) testing market. Cancer refers to a group of diseases marked by abnormal cell growth, which can invade surrounding tissues and spread to other parts of the body. Various factors, including lifestyle, environmental influences, and exposure risks, contribute to the increasing prevalence of cancer. Bioinformatics in IVD testing is transforming cancer diagnostics by providing precise, personalized genetic insights that improve early detection, guide treatment decisions, and enhance patient outcomes. For instance, in 2022, the National Association of Chronic Disease Directors (NACDD), a U.S.-based government agency, reported that approximately 40% of American adults live with multiple chronic conditions (MCC). The data also shows that having one chronic illness increases the likelihood of developing additional conditions, particularly with age. As a result, the growing prevalence of cancer is fueling demand for bioinformatics in the IVD testing market.

Leading companies in this market are focused on innovation, particularly in next-generation sequencing (NGS) technology. NGS enables rapid sequencing of entire genomes or specific DNA and RNA regions, facilitating comprehensive genetic analysis. For example, in May 2022, Illumina Inc. introduced a pan-cancer companion diagnostic (CDx) indication for its CE-marked TruSight Oncology Comprehensive (EU) test. This test identifies cancer patients with solid tumors harboring neurotrophic tyrosine receptor kinase (NTRK) gene fusions (NTRK1, NTRK2, or NTRK3), who may benefit from targeted therapy with Bayer's Vitrakvi (larotrectinib). The TSO Comprehensive (EU) test employs comprehensive genomic profiling (CGP), using next-generation sequencing to analyze multiple tumor genes and biomarkers from a single biopsy specimen, thereby determining each patient's specific cancer molecular profile.

In September 2024, QIAGEN N.V., a Germany-based molecular diagnostics company, partnered with Eli Lilly and Company to develop the first in vitro diagnostic (IVD) test for APOE genotyping, specifically for Alzheimer's disease, utilizing QIAGEN's QIAstat-Dx platform. This collaboration represents a significant advancement in neurodegenerative disease diagnostics, expanding QIAGEN's clinical applications and partnerships in diagnostic development. Eli Lilly and Company, a U.S.-based pharmaceutical firm, specializes in in vitro diagnostics (IVD) testing.

Major companies operating in the bioinformatics in in-vitro diagnostics (IVD) testing market are Siemens Healthineers, International Business Machines Corporation, Medtronic Inc., Parker Hannifin Corp., Illumina Inc, PerkinElmer Inc., QIAGEN N.V., Kollmorgen Corp, Bioreference Laboratories Inc., AssureRx Health Inc., Biodesix Inc., Crescendo Bioscience Inc., Affymetrix, Complete Genomics Inc., Aperico Technologies Inc., One Lambda Inc., Datech Oncology, Life Technologies, Signal genetics, CardioDx Inc.

North America was the largest region in the bioinformatics in in-vitro diagnostics (IVD) testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioinformatics in in-vitro diagnostics (IVD) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the bioinformatics in in-vitro diagnostics (IVD) testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bioinformatics in in-vitro diagnostics (IVD) testing market consists of revenues earned by entities by providing services such as clinical decision support systems, sequence analysis, and clinical genomics software. The market value includes the value of related goods sold by the service provider or included within the service offering. The bioinformatics in in vitro diagnostics (IVD) testing market also includes sales of sequencing tools and diagnostics tools. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bioinformatics In In-Vitro Diagnostics (IVD) Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bioinformatics in in-vitro diagnostics (ivd) testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bioinformatics in in-vitro diagnostics (ivd) testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bioinformatics in in-vitro diagnostics (ivd) testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Hardware; Software
• 2) By Type Of Test: Blood Based Tests; Tissue Based Tests
• 3) By Application: Cardiovascular Diseases; Chronic Diseases; Diabetes; Cancer; Other Applications
• Subsegments:
• 1) By Hardware: Analyzers; Laboratory Equipment; Data Storage Devices; Sensors And Detectors; Workstations And Data Processing Hardware
• 2) By Software: Bioinformatics Platforms; Data Management and Integration Software; Analytics And Interpretation Software; Cloud-Based Software Solutions; AI-Based Software For Diagnostics
• Companies Mentioned: Siemens Healthineers; International Business Machines Corporation; Medtronic Inc.; Parker Hannifin Corp.; Illumina Inc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Characteristics

3. Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Trends And Strategies

4. Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Growth Rate Analysis
• 5.4. Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Total Addressable Market (TAM)

6. Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Segmentation

• 6.1. Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hardware
• Software
• 6.2. Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood Based Tests
• Tissue Based Tests
• 6.3. Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiovascular Diseases
• Chronic Diseases
• Diabetes
• Cancer
• Other Applications
• 6.4. Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Analyzers
• Laboratory Equipment
• Data Storage Devices
• Sensors And Detectors
• Workstations And Data Processing Hardware
• 6.5. Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bioinformatics Platforms
• Data Management and Integration Software
• Analytics And Interpretation Software
• Cloud-Based Software Solutions
• AI-Based Software For Diagnostics

7. Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Regional And Country Analysis

• 7.1. Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market

• 8.1. Asia-Pacific Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market

• 9.1. China Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Overview
• 9.2. China Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market

• 10.1. India Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market

• 11.1. Japan Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Overview
• 11.2. Japan Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market

• 12.1. Australia Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market

• 13.1. Indonesia Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market

• 14.1. South Korea Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Overview
• 14.2. South Korea Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market

• 15.1. Western Europe Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Overview
• 15.2. Western Europe Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market

• 16.1. UK Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market

• 17.1. Germany Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market

• 18.1. France Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market

• 19.1. Italy Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market

• 20.1. Spain Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market

• 21.1. Eastern Europe Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Overview
• 21.2. Eastern Europe Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market

• 22.1. Russia Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market

• 23.1. North America Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Overview
• 23.2. North America Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market

• 24.1. USA Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Overview
• 24.2. USA Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market

• 25.1. Canada Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Overview
• 25.2. Canada Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market

• 26.1. South America Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Overview
• 26.2. South America Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market

• 27.1. Brazil Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market

• 28.1. Middle East Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Overview
• 28.2. Middle East Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market

• 29.1. Africa Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Overview
• 29.2. Africa Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Competitive Landscape And Company Profiles

• 30.1. Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Competitive Landscape
• 30.2. Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Company Profiles
  • 30.2.1. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. International Business Machines Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Medtronic Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Parker Hannifin Corp. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Illumina Inc Overview, Products and Services, Strategy and Financial Analysis

31. Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Other Major And Innovative Companies

• 31.1. PerkinElmer Inc.
• 31.2. QIAGEN N.V.
• 31.3. Kollmorgen Corp
• 31.4. Bioreference Laboratories Inc.
• 31.5. AssureRx Health Inc.
• 31.6. Biodesix Inc.
• 31.7. Crescendo Bioscience Inc.
• 31.8. Affymetrix
• 31.9. Complete Genomics Inc.
• 31.10. Aperico Technologies Inc.
• 31.11. One Lambda Inc.
• 31.12. Datech Oncology
• 31.13. Life Technologies
• 31.14. Signal genetics
• 31.15. CardioDx Inc.

32. Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market

34. Recent Developments In The Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market

35. Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market High Potential Countries, Segments and Strategies

• 35.1 Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer